NCT01722812View on ClinicalTrials.gov

Cromoglicate in Psoriasis

PHASE2CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

May 31, 2013

Conditions

Psoriasis

Interventions

DRUG

Cromoglicate

Twice daily topical treatment for 14 days

DRUG

Placebo

Twice daily topical treatment for 14 days

Trial Locations (1)

D-10117

Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin

Sponsors

Lead Sponsor

All Listed Sponsors

lead

LEO Pharma

INDUSTRY